Novel mutations of wolframin: A report with a look at the protein structure

Clinical Genetics

Volumn 79, Issue 1, 2011, Pages 96-99

  Alimadadi, A ^a   Ebrahim Habibi, A ^a   Abbasi, F ^a   Amoli, M M ^a   Sayahpour, F A ^a   Larijani, B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);

ADOLESCENT; ADULT; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; DIABETES MELLITUS; DNA STRAND; ENDOPLASMIC RETICULUM; EXON; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; HYPOGONADISM; INFORMED CONSENT; LETTER; MALE; MISSENSE MUTATION; OPTIC NERVE ATROPHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; WOLFRAM SYNDROME; WOLFRAM SYNDROME 1 GENE;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MODELS, MOLECULAR; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ANALYSIS; SIBLINGS; WOLFRAM SYNDROME; YOUNG ADULT;

EID: 78649991400     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01511.x     Document Type: Letter

References (25)

1. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995: 346: 1458-1463.
2. Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997: 34: 838-841.
3. Hardy C, Khanim F, Torres R et al. Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet 1999: 65: 1279-1290.
4. Zenteno JC, Ruiz G, Perez-Cano HJ et al. Familial Wolfram syndrome due to compound heterozygosity for two novel WFS1 mutations. Mol Vis 2008: 14: 1353-1357.
5. Nickl-Jockschat T, Kunert HJ, Herpertz-Dahlmann B et al. Psychiatric symptoms in a patient with Wolfram syndrome caused by a combination of thalamic deficit and endocrinological pathologies. Neurocase 2008: 15: 47-52.
6. Domenech E, Kruyer H, Gomez C et al. First prenatal diagnosis for Wolfram syndrome by molecular analysis of the WFS1 gene. Prenat Diagn 2004: 24: 787-789.
7. Medlej R, Wasson J, Baz P et al. Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab 2004: 89: 1656-1661.
8. Smith CJ, Crock PA, King BR et al. Phenotype-genotype correlations in a series of Wolfram syndrome families. Diabetes Care 2004: 27: 2003-2009.
9. Cano A, Rouzier C, Monnot S et al. Identification of novel mutations in WFS1 and genotype-phenotype correlation in Wolfram syndrome. Am J Med Genet A 2007: 143A: 1605-1612.
10. Minton JA, Hattersley AT, Owen K et al. Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes 2002: 51: 1287-1290.
11. Bespalova IN, Van Camp G, Bom SJ et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 2001: 10: 2501-2508.
12. Colosimo A, Guida V, Rigoli L et al. Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum Mutat 2003: 21: 622-629.
13. Giuliano F, Bannwarth S, Monnot S et al. French Group of WS. Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum Mutat 2005: 25: 99-100.
14. Eller P, Föger B, Gander R et al. Wolfram syndrome: a clinical and molecular genetic analysis. Med Genet 2001: 38: E37.
15. Middle F, Jones I, McCandless F et al. Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the Wolfram gene. Am J Med Genet 2000: 96: 154-157.
16. Tusnady GE, Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics 2001: 17: 849-850.
17. Hofmann S, Philbrook C, Gerbitz KD et al. Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 2003: 12: 2003-2012.
18. Zatyka M, Ricketts C, Da Silva Xavier G et al. Sodium-potassium ATPase 1 subunit is a molecular partner of Wolframin, an endoplasmic reticulum protein involved in ER stress. Hum Mol Genet 2008: 17: 190-200.
19. Torres R, Leroy E, Hu X et al. Mutation screening of the Wolfram syndrome gene in psychiatric patients. Mol Psychiatry 2001: 6: 39-43.
20. Cryns K, Sivakumaran TA, Van den Ouweland JM et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat 2003: 22: 275-287.
21. Sam W, Qin H, Crawford B et al. Homozygosity for a 4-bp deletion in a patient with Wolfram syndrome suggesting possible phenotype and genotype correlation. Clin Genet 2001: 59: 136-138.
22. D'Annunzio G, Minuto N, D'Amato E et al. Wolfram syndrome (diabetes insipidus, diabetes, optic atrophy, and deafness): clinical and genetic study. Diabetes Care 2008: 31: 1743-1745.
23. Hofmann S, Bauer MF. Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin. FEBS Lett 2006: 580: 4000-4004.
24. Sandhu MS, Weedon MN, Fawcett KA et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 2007: 39: 951-953.
25. Franks PW, Rolandsson O, Debenham SL et al. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia 2008: 51: 458-463.